X4 Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 8, 2024
X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on improving the lives of people with rare immune system diseases, has announced its plans to report second quarter 2024 financial results and provide corporate updates on August 8, 2024. The company will host a conference call and webcast at 8:30 a.m. ET on the same day.
Investors and interested parties can access the conference call by dialing 1-800-225-9448 (US) or 1-203-518-9708 (international) with the conference ID: X4PHARMA. A live webcast will also be available through the investor relations section of X4 Pharmaceuticals' website. Following the call, a webcast replay will be accessible on the company's website.
X4 Pharmaceuticals (Nasdaq: XFOR), un'azienda impegnata a migliorare la vita delle persone con malattie rare del sistema immunitario, ha annunciato i suoi piani per riportare i risultati finanziari del secondo trimestre del 2024 e fornire aggiornamenti aziendali il 8 agosto 2024. L'azienda ospiterà una teleconferenza e un webcast alle 8:30 a.m. ET lo stesso giorno.
Gli investitori e le parti interessate possono accedere alla teleconferenza componendo il numero 1-800-225-9448 (USA) o 1-203-518-9708 (internazionale) con l'ID conferenza: X4PHARMA. Un webcast dal vivo sarà disponibile anche attraverso la sezione relazioni con gli investitori del sito web di X4 Pharmaceuticals. Dopo la chiamata, una registrazione del webcast sarà accessibile sul sito dell'azienda.
X4 Pharmaceuticals (Nasdaq: XFOR), una empresa centrada en mejorar la vida de las personas con enfermedades raras del sistema inmunológico, ha anunciado sus planes para reportar los resultados financieros del segundo trimestre de 2024 y proporcionar actualizaciones corporativas el 8 de agosto de 2024. La empresa organizará una llamada de conferencia y un webcast a las 8:30 a.m. ET el mismo día.
Los inversores y partes interesadas pueden acceder a la llamada de conferencia marcando 1-800-225-9448 (EE. UU.) o 1-203-518-9708 (internacional) con el ID de conferencia: X4PHARMA. Asimismo, estará disponible un webcast en vivo a través de la sección de relaciones con los inversores del sitio web de X4 Pharmaceuticals. Tras la llamada, una grabación del webcast estará accesible en el sitio web de la empresa.
X4 Pharmaceuticals (Nasdaq: XFOR)는 희귀 면역 질환을 가진 사람들의 삶을 개선하는 데 중점을 두고 있는 회사로, 2024년 2분기 재무 결과를 보고하고 기업 업데이트를 제공할 계획을 2024년 8월 8일에 발표했습니다. 회사는 같은 날 오전 8시 30분 (ET)에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
투자자 및 관심 있는 분들은 1-800-225-9448 (미국) 또는 1-203-518-9708 (국제)로 전화하여 컨퍼런스 ID: X4PHARMA로 컨퍼런스 콜에 접속할 수 있습니다. X4 Pharmaceuticals의 웹사이트의 투자자 관계 섹션을 통해 라이브 웹캐스트도 이용할 수 있습니다. 콜 후에는 회사 웹사이트에서 웹캐스트 재생이 가능할 것입니다.
X4 Pharmaceuticals (Nasdaq: XFOR), une entreprise axée sur l'amélioration de la vie des personnes atteintes de maladies rares du système immunitaire, a annoncé ses plans pour communiquer les résultats financiers du deuxième trimestre 2024 et fournir des mises à jour d'entreprise le 8 août 2024. L'entreprise organisera une conférence téléphonique et un webcast à 8h30 (ET) le même jour.
Les investisseurs et les parties intéressées peuvent accéder à la conférence téléphonique en composant le 1-800-225-9448 (États-Unis) ou le 1-203-518-9708 (international) avec l'ID de conférence : X4PHARMA. Un webcast en direct sera également disponible via la section des relations investisseurs du site web de X4 Pharmaceuticals. Après l'appel, une rediffusion du webcast sera accessible sur le site de l'entreprise.
X4 Pharmaceuticals (Nasdaq: XFOR), ein Unternehmen, das sich auf die Verbesserung des Lebens von Menschen mit seltenen Krankheiten des Immunsystems konzentriert, hat seine Pläne bekannt gegeben, die Finanzergebnisse für das zweite Quartal 2024 zu berichten und Unternehmensaktualisierungen am 8. August 2024 bereitzustellen. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und ein Webcast veranstalten.
Investoren und Interessierte können auf die Telefonkonferenz zugreifen, indem sie 1-800-225-9448 (USA) oder 1-203-518-9708 (international) anrufen und die Konferenz-ID: X4PHARMA eingeben. Ein Live-Webcast wird ebenfalls über den Bereich für Investorenbeziehungen auf der Website von X4 Pharmaceuticals verfügbar sein. Nach der Konferenz wird eine Aufzeichnung des Webcasts auf der Website des Unternehmens zugänglich sein.
- None.
- None.
BOSTON, July 30, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will report financial results for the second quarter ended June 30, 2024 and provide corporate updates on Thursday, August 8, 2024.
The company will host a conference call and webcast on the same day at 8:30 a.m. ET. The conference call can be accessed by dialing 1-800-225-9448 from the United States or 1-203-518-9708 internationally, followed by the conference ID: X4PHARMA. The live webcast will be accessible through the investor relations section of X4 Pharmaceuticals’ website at www.x4pharma.com. Following the completion of the call, a webcast replay will be available on the website.
About X4 Pharmaceuticals
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging our expertise in CXCR4 and immune system biology, we have successfully developed mavorixafor, which has received U.S. approval as XOLREMDI™ (mavorixafor) capsules in its first indication. We are also evaluating the use of mavorixafor in additional potential indications. X4 corporate headquarters are in Boston, Massachusetts and our research center of excellence is in Vienna, Austria. For more information, please visit our website at www.x4pharma.com.
Company Contact:
José Juves
Head of Corporate & Patient Affairs
jose.juves@x4pharma.com
Investor Contact:
Daniel Ferry
Managing Director, LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
FAQ
When will X4 Pharmaceuticals (XFOR) report its Q2 2024 financial results?
How can investors access X4 Pharmaceuticals' (XFOR) Q2 2024 earnings call?
What time is X4 Pharmaceuticals' (XFOR) Q2 2024 earnings call scheduled for?
Where can I find the replay of X4 Pharmaceuticals' (XFOR) Q2 2024 earnings call?
